Cargando…
Anti‐PrP(C) antibody rescues cognition and synapses in transgenic alzheimer mice
OBJECTIVE: Amyloid‐beta oligomers (Aßo) trigger the development of Alzheimer's disease (AD) pathophysiology. Cellular prion protein (PrPC) initiates synaptic damage as a high affinity receptor for Aßo. Here, we evaluated the preclinical therapeutic efficacy of a fully human monoclonal antibody...
Autores principales: | Cox, Timothy O., Gunther, Erik C., Brody, A. Harrison, Chiasseu, Marius T., Stoner, Austin, Smith, Levi M., Haas, Laura T., Hammersley, Jayne, Rees, Gareth, Dosanjh, Bhupinder, Groves, Maria, Gardener, Matthew, Dobson, Claire, Vaughan, Tristan, Chessell, Iain, Billinton, Andrew, Strittmatter, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414488/ https://www.ncbi.nlm.nih.gov/pubmed/30911579 http://dx.doi.org/10.1002/acn3.730 |
Ejemplares similares
-
PrP(ST), a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease
por: Friedman-Levi, Yael, et al.
Publicado: (2013) -
Correction: PrP(ST), a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease
por: Friedman-Levi, Yael, et al.
Publicado: (2015) -
Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
por: Sakudo, Akikazu, et al.
Publicado: (2015) -
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
por: Tang, Si Jie, et al.
Publicado: (2020) -
The Structure of PrP(Sc) Prions
por: Wille, Holger, et al.
Publicado: (2018)